Procter & Gamble Hygiene and Health Care Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
PGHH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Procter & Gamble Hygiene and Health Care Limited reported audited financial results for FY2026 (12 months ended March 31, 2026). Revenue from operations stood at ₹4,29,042 lakhs, with profit after tax at ₹85,650 lakhs and total comprehensive income at ₹86,079 lakhs. EPS (basic) was ₹263.86. The Board recommended a dividend of ₹60 per equity share (face value ₹10). Note: The previous financial year was only 9 months (July 2024 to March 2025) due to change in financial year-end from June to March, making direct comparison invalid. The statutory auditors (Kalyaniwalla & Mistry LLP) issued an unmodified (clean) opinion. Cash and cash equivalents increased to ₹55,702 lakhs from ₹46,637 lakhs, with operating cash flows at ₹92,408 lakhs for the year.
The results are positive with strong cash generation and clean audit. Dividend payout of ₹60/share signals confidence. However, shareholders should note that year-on-year comparisons are skewed due to the change in financial year-end, requiring a 9-month restated view for proper analysis.